Clinical trial
DFN-02 Open Label Safety Study in Patients With Acute Migraine
NCT02279082 is registered in ClinicalTrials.gov with Dr. Reddy's Laboratories Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DFN-02 Open Label Safety Study in Patients With Acute Migraine
- Lead sponsor
- Dr. Reddy's Laboratories Limited
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2014
- Completion date
- March 31, 2016
- Enrollment
- 167 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
acute migraine